Alladapt Immunotherapeutics, Inc. 

Senior Preferred Stockholder Information Submission

As part of Alladapt Immunotherapeutics, Inc.'s final liquidation process following its formal dissolution, we are collecting payment information from holders of Series B, B-1, and B-2 Preferred Stock. If you received a notice regarding your entitlement to liquidation proceeds, please complete the form below to facilitate the distribution of your dividend. Submission of this information is necessary to ensure prompt and accurate processing.

Stockholder Payment Information Form